From Surf Wiki (app.surf) — the open knowledge base
Pipazetate
Chemical compound
Chemical compound
| Drugs.com =
| elimination_half-life =
Pipazetate () (brand names Dipect, Lenopect, Selvigon, Theratuss, Toraxan), or pipazethate (), is a 1-azaphenothiazine drug that was briefly marketed as a cough suppressant. It binds to the sigma-1 receptor with an IC50 value of 190 nM. It also has local anesthetic action, and in large doses can produce seizures.
As the brand name Theratuss, it was approved by the FDA in 1962, on evidence of safety only. It was withdrawn from the US market in 1972 when the manufacturer, Bristol Myers Squibb, failed to produce evidence of efficacy. Clinical studies showed that it did not decrease cough frequency at recommended dosages.
Infrequent side effects include nausea, vomiting, drowsiness, fatigue, rash, tachycardia and seizures.
Synthesis
Note: 1-azaphenothiazine is also used for making Prothipendyl & Isothipendyl.
The reaction of 1-azaphenothiazine [261-96-1] (1) with phosgene gives 1-azaphenothiazine-10-carbonyl chloride [94231-78-4] (2). The reaction of this reactive intermediate with 2-[2-(piperidyl)ethoxy]ethanol [3603-43-8] (3) gives the ester, thus completing the synthesis of Pipazethate (4).
References
References
- (14 November 2014). "The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies". Springer.
- (2000). "Index Nominum 2000: International Drug Directory". Taylor & Francis.
- (October 10, 1988). "Dextromethorphan binding sites in the guinea pig brain.". Cellular and Molecular Neurobiology.
- (2004). "Farmacología clínica y terapéutica médica".
- (August 5, 1972). "Certain Preparations Containing Dihyprylone or Pipazethate Hydrochloride; Notice of Withdrawal of Approval of New-Drug Applications". Federal Register.
- Council on Drugs. (1971). "AMA Drug Evaluations". [[American Medical Association]].
- Schuler, Wilhelm A.; Klebe, Hans; Schlichtegroll, Ansgar V. (1964). "Synthesen von 4-Aza-phenothiazinen, II. Derivate der 4-Aza-phenothiazin-10-carbonsäure". Justus Liebigs Annalen der Chemie. 673 (1): 102–112. doi:10.1002/jlac.19646730114.
- Schuler Wilhelm Alfons, {{US patent. 2989529 (1961 to Degussa).
- Bernd Dr. Lehmann & Bernhard Petrat, {{Cite patent. EP. 0527298 (1997 to Meda Pharma GmbH and Co KG).
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Pipazetate — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report